Articles with public access mandates - Amit V PandeyLearn more
Not available anywhere: 1
Short stature in two siblings heterozygous for a novel bioinactive GH mutant (GH-P59S) suggesting that the mutant also affects secretion of the wild-type GH
V Petkovic, MC Miletta, AM Boot, M Losekoot, CE Flück, AV Pandey, ...
European journal of endocrinology 168 (3), K35-K43, 2013
Mandates: Swiss National Science Foundation
Available somewhere: 80
NADPH P450 oxidoreductase: structure, function, and pathology of diseases
AV Pandey, CE Flück
Pharmacology & therapeutics 138 (2), 229-254, 2013
Mandates: Swiss National Science Foundation
Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation
CE Flück, M Meyer-Böni, AV Pandey, P Kempná, WL Miller, EJ Schoenle, ...
The American Journal of Human Genetics 89 (2), 201-218, 2011
Mandates: Swiss National Science Foundation
NADPH–cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology
DS Riddick, X Ding, CR Wolf, TD Porter, AV Pandey, QY Zhang, J Gu, ...
Drug Metabolism and Disposition 41 (1), 12-23, 2013
Mandates: Swiss National Science Foundation, US National Institutes of Health …
Ten Novel Mutations in the NR5A1 Gene Cause Disordered Sex Development in 46,XY and Ovarian Insufficiency in 46,XX Individuals
N Camats, AV Pandey, M Fernandez-Cancio, P Andaluz, M Janner, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), E1294-E1306, 2012
Mandates: Swiss National Science Foundation, Government of Spain
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
AV Pandey, P Kempna, G Hofer, PE Mullis, CE Fluck
Molecular Endocrinology 21 (10), 2579-2595, 2007
Mandates: Swiss National Science Foundation
P450 oxidoreductase deficiency–a new form of congenital adrenal hyperplasia
CE Flück, A Pandey, N Huang, V Agrawal, W Miller
Endocrine Dev 13, 67-81, 2008
Mandates: Swiss National Science Foundation
Pharmacogenomics of human P450 oxidoreductase
AV Pandey, P Sproll
Frontiers in pharmacology 5, 103, 2014
Mandates: Swiss National Science Foundation
Steroidogenesis of the testis–new genes and pathways
CE Flück, AV Pandey
Annales d'endocrinologie 75 (2), 40-47, 2014
Mandates: Swiss National Science Foundation
Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia
CE Flück, AV Pandey, B Dick, N Camats, M Fernández-Cancio, ...
PloS one 6 (5), e20178, 2011
Mandates: Swiss National Science Foundation
P450 Oxidoreductase deficiency: analysis of mutations and polymorphisms
FZ Burkhard, S Parween, SS Udhane, CE Flück, AV Pandey
The Journal of steroid biochemistry and molecular biology 165, 38-50, 2017
Mandates: Swiss National Science Foundation
Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice
L Sapra, HY Dar, A Bhardwaj, A Pandey, S Kumari, Z Azam, V Upmanyu, ...
Scientific reports 11 (1), 1807, 2021
Mandates: Department of Biotechnology, India, Department of Science & Technology, India
Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome
N Marti, JA Galván, AV Pandey, M Trippel, C Tapia, M Müller, A Perren, ...
Molecular and cellular endocrinology 441, 116-123, 2017
Mandates: Swiss National Science Foundation
Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism
CE Flück, PE Mullis, AV Pandey
Biochemical and biophysical research communications 401 (1), 149-153, 2010
Mandates: Swiss National Science Foundation
Of marsupials and men:“Backdoor” dihydrotestosterone synthesis in male sexual differentiation
A Biason-Lauber, WL Miller, AV Pandey, CE Flück
Molecular and cellular endocrinology 371 (1-2), 124-132, 2013
Mandates: Swiss National Science Foundation, US National Institutes of Health
CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2
J Malikova, S Brixius-Anderko, SS Udhane, S Parween, B Dick, ...
The Journal of steroid biochemistry and molecular biology 174, 192-200, 2017
Mandates: Swiss National Science Foundation
Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46, XX newborn, undervirilization of the 46, XY brother, but no virilization of the …
N Bouchoucha, D Samara-Boustani, AV Pandey, H Bony-Trifunovic, ...
Molecular and cellular endocrinology 390 (1-2), 8-17, 2014
Mandates: Swiss National Science Foundation
Restoration of mutant cytochrome P450 reductase activity by external flavin
C Nicolo, CE Flück, PE Mullis, AV Pandey
Molecular and cellular endocrinology 321 (2), 245-252, 2010
Mandates: Swiss National Science Foundation
Mutations and Polymorphisms in the Human Argininosuccinate Lyase (ASL) Gene
C Balmer, AV Pandey, V Rüfenacht, JM Nuoffer, P Fang, LJ Wong, ...
Human mutation 35 (1), 27-35, 2014
Mandates: Swiss National Science Foundation
Clinical and biochemical consequences of p450 oxidoreductase deficiency
CE Flück, AV Pandey
Pediatric Adrenal Diseases 20, 63-79, 2011
Mandates: Swiss National Science Foundation
Publication and funding information is determined automatically by a computer program